Differences in lung bioavailability between HFA and CFC formulations of fluticasone propionate
Tools
Wilson, Andrew M., Sims, Erika J., Orr, Linda C. and Lipworth, Brian J. (1999) Differences in lung bioavailability between HFA and CFC formulations of fluticasone propionate. Lancet, 354 (9187). pp. 1357-1358. ISSN 1474-547X
Full text not available from this repository. (Request a copy)Item Type: | Article |
---|---|
Additional Information: | Source:RK Note: |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Depositing User: | EPrints Services |
Date Deposited: | 25 Nov 2010 11:12 |
Last Modified: | 29 Apr 2022 00:16 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/14705 |
DOI: | 10.1016/S0140-6736(99)03581-3 |
Actions (login required)
![]() |
View Item |